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implication in Tunisian patients with coronary
artery disease
Mohamed Yahia Hrira1,2*, Latifa Chkioua1,2, Afef Slimani3, Henda Chahed1,2, Habib Mosbah4, Hamda Ben Khaldoun5,
Salima Ferchichi1,2, Faouzi Addad5 and Abdelhedi Miled1,2Abstract: Coronary artery disease (CAD) is a multifactorial disease where genetic and environmental factors interact
in complex ways to cause the disease. Heat shock protein genes are involved in the progress of CAD. This implies
that genetic variants of Hsp70–2 genes might contribute to the development of the CAD.
Aim of study: The aim of this study was to characterize statistical correlation of linkage between lipid profiles,
polymorphism PstI site of Hsp70–2 gene and CAD.
Patients and methods: This study was carried out on Tunisian patients with CAD recruited from Hospital of
Fattouma Bourguiba of Monastir-Tunisia. Polymerase chain reaction and restriction enzymes were used to
determine the genotypic distributions in 252 unrelated patients and 151 healthy control subjects. Further, ApoA-I
and ApoB as well as the serum total of cholesterol, HDL, triglyceride, and hs-CRP levels were measured.
Results: We showed a decreased level of ApoA-I, whereas the levels of each of ApoB and hs-CRP were increased in
patients with CAD compared with control group. In addition our studies of a polymorphic PstI site of Hsp70-2 gene
at position 1267 of the Hsp70–2 gene have revealed that the allelic frequency of P2 was significantly more frequent
in CAD patients than controls group (p=0.007, OR=1.495). The genotypic distribution showed a high incidence of
P2/P2 genotype in CAD patients (0.190) compared to healthy control (0.009) with reach significant difference
(p=0.006). The P2 carriers showed a significantly increased of Total-Cholesterol (CT) and C-reactive protein (hs-CRP)
levels in CAD patients (p=0.008 and p=0.018, respectively).
Conclusion: The high incidence of P2-Hsp70-2 genotype in CAD patients and the significantly association of P2/P2
genotype with elevated Total Cholesterol and hs-CRP levels, supported that P2–Hsp70–2 genotype has
susceptibility implication in CAD and could increased the risk of CAD in Tunisian population.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1118340895703689
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Coronary artery disease (CAD) is a multifactorial disease
that combines genetic and environmental factors [1]. CAD
is a complex disease with high morbidity and mortality in
Tunisian population [2]. There are several emerging risk fac-
tors for CAD including markers of oxidative stress, inflam-
mation and autoimmunity. Atherogenesis is a progressive,* Correspondence: harira_yahia@yahoo.fr
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reproduction in any medium, provided the ormulti-step process requiring an ordered sequence of events,
in which progress along the disease pathway is driven by risk
factors [3]. A cell stress response appears to be a pivotal
early event in atherogenesis. The heat shock proteins (Hsps)
are potential targets for immune responses, as they may be
themselves altered during exposure to the stress response,
and are usually not found in the extracellular milieu; they
may therefore directly contribute to the inflammatory
process [4].
Heat shock proteins (HSPs) are a family of proteins that
can be expressed in response to a variety of stress stimuli,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cytokines, amino acid analogues, oxidative stress, or ische-
mia. The HSPs play an important role in the maintenance of
cellular integrity and viability [5]. HSPs are classified to seven
families according to their molecular weight: HSP10, small
HSPs (12 – 43 kDa), HSP40, HSP60, HSP70, HSP90 and
large HSPs (100 – 110 kDa). HSPs belong to family of stress
proteins, which also consist of glucose-regulated proteins
(grps), ubiquitin and the lectin chaperones calnexin and cal-
reticulin [6]. Interestedly the 70–kDa family (Hsp70) and
according to to the new nomenclature the human genome
encodes 13 members of the HSPA (HSP70) family. The
most studied genes are HSPA1A and HSPA1B, the products
of which differ only by two amino acids and which are
believed to be fully interchangeable proteins [6]. In advanced
atherosclerotic lesions, HSP70 is over expressed in several
cell types, including monocytes, macrophages, dendritic cells
and smooth muscle cells. In early atherosclerotic lesions,
however, only dendritic cells, which are key cells in the im-
mune response, over express HSP70 [7]. An inverse relation
between HSP70 and atherosclerosis has been reported by
several groups. low serum HSP70 levels have been suggested
to predict the development of atherosclerosis [8]. In hyper-
tensive patients, increased concentrations of circulating
HSP70 correlated with decreased intima/media thickness
[9]. In another study by Zhu et al., high serum levels of
HSP70 were found to be associated with a low risk of coron-
ary artery disease [10]. We have reported that plasma
HSP70 concentrations were decreased in patients with ca-
rotid atherosclerosis relative to control healthy subjects [11].
Previous studies suggested that 1267 Hsp70 polymorph-
ism has a contributory marker in different diseases such as
the association between obesity and P2-Hsp70-2 homozy-
gote genotype [12]. It was reported that HSPA1B +1267
allele G was associated with higher serum Hsp70 levels in
patients with severe chronic heart failure [13]. A strict cor-
relation was found among 1267 HSP70–2 polymorphism,
enhanced pro-inflammatory cytokines and cerebral ischae-
mia in old type 2 diabetic-atherosclerotic patients [14].
Another study suggests that 1267 HSP70–2 polymorphism
and zinc deficiency are independently associated with
ischaemic cardiomiopathy [15].
These finding prompted us to investigate, in patients and
healthy controls, the potential association of the poly-
morphism of Hsp70–2 gene with risk of CAD. For this pur-
pose, we evaluated the genotypic frequency of 1267 Hsp70
polymorphism in patients with CAD. The relationship




A total of 252 patients, with coronary artery disease (CAD)
were recruited through the Cardiovascular Department ofFattoumaBourguiba hospital (Monastir, Tunisia) (Add-
itional file 1: Table S1), who underwent their first coronary
angiography for evaluation the presence of CAD were
assessed and investigated in the Biochemistry Laboratory
of University Hospital of FarhatHached Sousse. Patients
who were young (<45 years) and old age (>75 years) and
had inflammatory diseases, valvular heart disease, cancers
or rheumatoid arthritis were excluded. The Control group
includes 151 subjects all, free of any history of obesity,
hypertension, dyslipidemia, diabetes mellitus, or CAD. All
participants were of Tunisian origin and gave their
informed consent for this study.Biochemical analysis
For each patient, blood samples were drawn following over-
night fasting into tubes containing EDTA and plasma was
immediately separated by centrifugation. The biochemical
analysis confirmed the coronary artery diagnosis for all stud-
ied patients. Total cholesterol, HDL, triglyceride (TG),
C-reactive protein (hs-CRP), and apolipoproteins serum
levels were measured. Total cholesterol, HDL and TG
serum concentrations were assayed by enzymatic techniques
(Randox-Antrim, UK). LDL cholesterol was calculated by
using the Friedewald formula [16].
Serum ApoA-I, ApoB, and hs-CRP were determined
using a highly sensitive immunonephelometric assay
(BNII - Dade Behring) [17].Genetic analysis
Genomic DNA was extracted from peripheral blood leuko-
cytes using a standard phenol/chloroforme procedure [18].
Polymerase chain reaction (PCR) was carried out in 25 μl
total volume containing 500 ng genomic DNA, 0.2 mmol/L
dNTP, 0.8 pmol of each primer, 1.5 mM MgCl2 and 1 U
DNATaq polymerase.
The coding sequence of the hsp70–2 gene was ampli-
fied from genomic DNA by using sequence specific
oligonucleotide primers: the 5’ primer: 5’-TCCGAAGGA
CTGAGCTCTTG-3’ was used in combination with the
3’ primer: 5’-CAGCAAAGTCCTTGAGTCCC-3’. Ampli-
fication was accomplished by initial incubation at 94°C
for 5 minutes followed by 30 cycles of incubation at
94°C, 60°C for 1 minute each, 72°C for 3 minutes, fol-
lowed by a final incubation at 72°C for 10 minutes.
The corresponding PCR products were digested
with PstI to assess the polymorphism of the Hsp70–2
at position 1267. The lack of the polymorphism PstI
site within the HSP70–2 gene generated a single
product of 2075 pb (HSP-P1 allele). The presence of
a PstI site was indicated by the cleavage of the
2075bp amplified product to yield fragments of 1139
and 936 bp (HSP-P2 allele).
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Statistical analysis was performed using version 17.0 of the
Statistical Package for the Social Sciences: SPSS (SPSS Inc.,
Chicago, Illinois, USA). Data are presented as mean ±
standard deviation for continuous variables, or as medians
and interquartile ranges for variables with a skewed distribu-
tion. Differences between two groups were evaluated by the
unpaired Student t test for continuous variables or the non
parametric Mann-Whitney test for discontinuous variables.
Qualitative variables were assessed with the Pearson’s χ2 test.
Allele frequencies, genotype frequencies, odds ratios (ORs)
and 95% confidence intervals (CIs) were all estimated by
Chi-squared analyses and Hardy–Weinberg equilibrium was
calculated. A value of p <0.05 was considered significant.
Results
Clinic-biochemical parameters and coronary artery
disease
Anthropometric and clinical characteristics (age, gender) of
the studied population are summarized in Additional file 1:
Table S1. We noted a statistically significant increase of total
cholesterol, TG, Apo B and hs-CRP and inversely a signifi-
cant decrease in ApoA-I, and HDL in all patients compared
with controls (Additional file 1: Table S1).
Polymorphism of the Hsp70-2 and coronary artery
disease
The genotypic and allelic frequencies of Hsp70–2 poly-
morphism in CAD and controls groups are shown in Add-
itional file 2: Table S2. Genotype distribution of Hsp70–2
polymorphism was in Hardy–Weinberg equilibrium. The
incidence of P2 allele was more frequent in CAD patients
(0.432) than controls group (0.337) with reach significance
difference (p=0.007). Similarly, the frequency of the P2/P2
was higher in patients (0.190) than in control group (0.099)
(p=0.006). These results indicate that the relative risk of cor-
onary artery associated with the Hsp70–2 gene is confined
to P2/P2 homozygote (OR= 2.49 [1.284–4.859]).
Correlation between Hsp70-2 polymorphisms and clinic-
biochemical parameters
Analysis of the clinic-biochemical characteristics of patients
with or without the Hsp70–2–P2/P2 is showed in Add-
itional file 3: Table S3. We showed a strongly association be-
tween P2 allele and a higher CT and hs-CRP levels in CAD
patients with reach significance difference (p= 0.004 and
p=0.026, respectively). But this association was not found in
controls groups.
Discussion
Coronary artery disease is characterized by an inflammatory
status and it represents the major cause of death in elderly
[14]. In Tunisia, the allele and genotype frequencies of
Hsp70-2 were observed in several studies [12,19,20] whichevaluated a highly significant association between poly-
morphisms in Hsp70 gene and studied diseases.
In this study we show for the first time the association be-
tween lipid profiles, polymorphism PstI site of Hsp70–2
gene and CAD. Biochemical analysis results showed a
decreased level of ApoA- and HDL and inversely an
increased level of total cholesterol, triglyceride, Apo B and
hs-CRP in patients with CAD compared with control group.
Furthermore, a significant correlation of elevated level of
some biochemical parameters with CAD was explained by
different mechanisms: Elevated levels of LDL cholesterol are
associated with an increased risk of coronary heart disease,
stroke, and peripheral artery disease. LDL lipoprotein depos-
its cholesterol along the inside of artery walls, causing the
formation of cholesterol plaque. This accumulation causes
thickening of the artery walls and narrowing of the arteries
which decreases blood flow through the narrowed area [21].
In addition, elevated levels of C-reactive protein (CRP), a
protein that appears in the bloodstream during many in-
flammatory processes, are associated with acute coronary
events. CRP may be used as a predictor of cardiovascular
disease based on its correlation with the other known
cardiac risk factors and their role in the formation of athero-
sclerosis [22].
Controversial studies regarding the role of Apo A-I as a
risk factor of CAD. Indeed, same studies found a positive
correlation but others did not [23].
Additionally, P2-CAD patients displayed increased total
serum cholesterol, TG and hs-CRP in comparison to
P1-CAD patients (Additional file 3: Table S3), while no dif-
ferences were observed in serum ApoA-I and HDL between
P2/P2 and P1/P1 patients, (Additional file 3: Table S3). Ac-
cordingly, patients with P2/P2 genotype are more predis-
posed to plaque accumulation than those with the P1/P1
genotype and are at risk for possible acute coronary events
and the progression of CAD.
However, Hsp70-2 polymorphism does seem to affect hs-
CRP (Additional file 3: Table S3). The specific role of
Hsp70 within the plaques is still unclear and the data are
contradictory. A positively correlation was found between
serum HSP70 and asymmetric dimethylarginine (ADMA)
with high hs-CRP levels in type 2 diabetes patients suggest
that both ADMA and HSP70 have similarly an inhibitory
function on nitric oxide synthase (NOS) in inflammatory
and oxidative stress situation [24]. In addition molecular
analysis of a polymorphic PstI site of Hsp70–2 gene lying in
the coding region at position 1267 of the Hsp70-2 gene
have revealed that the heterozygous P1/P2 genotype was
significantly more frequent in patient group and control pa-
tient. The homozygous P2/P2 genotype was significantly
more frequent in patient group and significantly less fre-
quent in control group (Additional file 2: Table S2). Our
results are consistent with results reported in the literature
[23]. Patients with P2 genotype are more predisposed to
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coronary arteries than those with the P1 genotype and are
at risk for possible rupture and start limiting blood flow to
the heart muscle [24].
Our report highlighted a direct correlation between P2–
Hsp70-2 homozygous, elevated level of LDL cholesterol, hs-
CRP and CAD. Therefore, a higher significant association
was found in patients group compared with controls. Other
studies indicate the association of high Hsp70 levels with
low CAD risk. The inverse relation between Hsp70 serum
levels and CAD are conjectural [25]. This study suggest that
the serum level of HSP70 protein is a potent marker for
lowered CAD susceptibility and may be helpful, along with
other currently recognized risk factors, in more accurately
conveying the overall risk of an individual for CAD [25].
Our data seem to suggest that the presence of 1267
Hsp70–2 polymorphism in patients with CAD play a detri-
mental role in the accumulation of plaques and the forma-
tion of atherosclerosis.
The expression level of Hsp70–2 gene could be among
factors affecting the regulation of cholesterol rate or other
mechanisms exacerbating this step. It has been shown that
Hsp70–2 plays a role in the route of synthesis of cholesterol,
folding and subcellular localization of hs-CRP protein. Fur-
ther studies involving larger patient populations will be
required to confirm this hypothesis.
Conclusions
Our findings suggest that homozygous P2–Hsp70–2 geno-
type is associated with plasma levels of Total-cholesterol
and hs-CRP in a large patient population with CAD. Further
investigations and works are needed to confirm these results
and to clarify the mechanisms underlying this association.
Consent
Written informed consent was obtained from the patient
for publication of this case report. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
Additional files
Additional file 1: Table S1. Clinical and biological characteristics of
CAD patients and healthy controls.
Additional file 2: Table S2. Hsp70–2 genotype distribution in control
subjects and in patients with Coronary artery disease.
Additional file 3: Table S3. Biochemical characteristics of Clinic-
coronary artery disease patients and control groups with or without the
Hsp70–2–P2/P2.
Abbreviations
CAD: Coronary artery disease; ACE: Angiotensin Converting Enzyme;
apo A-I: apolipoprotein A-I; apo B: apolipoprotein B; Hsp: Heat shock
proteins; TG: Triglyceride; hs-CRP: High Sensitivity C-Reactive Protein;
PCR: Polymerase Chain Reaction; OR: Odds Ratio.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MYH and LC: wrote the manuscript. AS and HM participated in data analysis.
BKH and FA revised the manuscript. SF and AM revised the manuscript and
save final approval of the version to be published. All authors read and
approved the final manuscript.
Acknowledgements
We thank Dr. Mohamed BEN FARHAT and his colleagues of the
cardiovascular department at University Hospital Fattouma Bourguiba in
Monastir (Tunisia) for providing samples. This work is part of a doctoral thesis
by Hrira Mohamed Yahia whose research was supported financially by
“Ministère de l'Enseignement Supérieur, de la Recherche Scientifique et de la
Technologie-Tunisie” through a grant to “Laboratoire de Biochimie CHU
Farhat Hached Sousse”.
Author details
1Laboratory of Biochemistry CHU Hached, Sousse, Tunisia. 2Research Unit 07/
UR/06, Faculty of Pharmacy, Monastir, Tunisia. 3Unit of Research, Genetic and
Biologic Factors of Atherosclerosis, Faculty of Medicine, Monastir, Tunisia.
4Laboratory of Biochemistry and Enzyme Engineering of Lipases, ENIS Sfax,
Tunisia. 5Department of Cardiology, CHU Fattouma Bourguiba, Monastir,
Tunisia.
Received: 4 April 2012 Accepted: 21 May 2012
Published: 26 July 2012
References
1. Hrira MY, Kerkeni M, Hamda BK, Chahed H, Ferchichi S, Addad F, Limam HB,
Miled A: Apolipoprotein A-I, polipoprotein B, high-sensitivity C-reactive
protein and severity of coronary artery disease in tunisian population.
Cardiovasc Pathol 2012, 21(6):455-60.
2. Abderrahim E, Zouaghi K, Hedri H, et al: Renal replacement therapy for
diabetic end-stage renal disease. Experience of a Tunisian Hospital Centre.
Diabetes Metab 2001, 27:584–590.
3. Ferns GA: Multiple step-variable pathway hypothesis: a reason why
predictions fail in atherosclerosis. Med Hypotheses 2008, 71:923–926.
4. Ghayour-Mobarhan M, Rahsepar AA, Tavallaie S, Rahsepar S, Ferns GA: The
potential role of heat shock proteins in cardiovascular disease: evidence
from in vitro and in vivo studies. Adv Clin Chem 2009, 48:27–72.
5. Kiang JG, Tsokos GC: Heat shock protein 70 kDa: molecular biology,
biochemistry, and physiology. Pharmacol Ther 1998, 80:183–201.
6. Agata B-D, Marcin B, Mikhailidis DP, Jacek R, Maciej B: HSP 70 and
atherosclerosis –protector or activator? Expert Opin Ther Targets 2009,
13(3):307-17.
7. Mehta TA, Greenman J, Ettelaie C, Venkatasubramaniam A, Chetter IC,
McCollum PT: Heat Shock Proteins in Vascular Disease. Eur J Vasc
Endovasc Surg 2005, 29:395–402.
8. Madrigal-Matute J, Martin-Ventura JL, Blanco-Colio LM, Egido J, Michel J-B,
Meilhac O: Heat-shock proteins in cardiovascular disease. Adv Clin Chem
2011, 54:1–43.
9. Pockley AG, Georgiades A, Thulin T, De FU, Frostegard J: Serum heat shock
protein 70 levels predict the development of atherosclerosis in subjects
with established hypertension. Hypertension 2003, 42:235–238.
10. Zhu J, Quyyumi A, Wu H, Csako G, Rott D, Zalles-Ganley A, Ogunmakinwa J,
Halcox J, Stephen E: Increased serum levels of heat shock protein 70 are
associated with low risk of coronary artery disease. Arterioscler Thromb
Vasc Biol 2003, 23:1055–1059.
11. Martin-Ventura JL, Leclercq A, Blanco-Colio LM, Egido J, Rossignol P, Meilhac
O, Michel J-B: Low plasma levels of HSP70 in patients with carotid
atherosclerosis are associated with increased levels of proteolytic
markers of neutrophil activation. Atherosclerosis 2007, 194:334–341.
12. Zouari Bouassida K, Chouchane I, Jellouli K, Chérif S, Haddada S, Gabbouj S,
Danguir J: Polymorphism of stress protein HSP70-2 gene in Tunisians:
susceptibility implications in type 2 diabetes and obesity. Diabetes Metab
2004, 30:175–180.
13. Gombos T, Förhécz Z, Pozsonyi Z, Jánoskuti L, Prohászka Z: Interaction of
serum 70-kDa heat shock protein levels and HspA1B (+1267) gene
Hrira et al. Diagnostic Pathology 2012, 7:88 Page 5 of 5
http://www.diagnosticpathology.org/content/7/1/88polymorphism with disease severity in patients with chronic heart
failure. Cell Stress and Chaperones 2008, 13:199–206.
14. Giacconi R, Caruso C, Lio D, Muti E, Cipriano C, Saba V, Boccoli G, Gasparini
N, Malavolta M, Mocchegiani E: 1267 HSP70-2 polymorphism as a risk
factor of statins on adhesion molecule expression in endothelial cells.
for carotid plaque rupture and cerebral ischaemia in old type 2
diabetes-atherosclerotic patients. Mech Ageing Dev 2005, 126:866–873.
15. Giacconi R, Cipriano C, Muti E, Costarelli L, Malavolta M, Caruso C, Lio D,
Mocchegiani E: Involvement of −308 TNF-a and 1267 Hsp70-2
polymorphisms and zinc status in the susceptibility of coronary artery
disease (CAD) in old patients. Biogerontology 2006, 7:347–356.
16. Rader DJ, Hoeg JM, Brewer HB Jr: Quantitation of plasma apolipoproteins
in the primary and secondary prevention of coronary artery disease. Ann
Intern Med 1994, 120:1012–1025.
17. Baudner S, Bienvenu J, et al: The certrification of matrix reference for
immunochemical measurement of 14 humman serum proteins. CRM
470 Brussels: Community Bureau of reference, commission of the
European communities. BCR information 1993, 1–172. Reference materials,
report EUR 15243 EN ISSN 1018-5593°.
18. Sambrook J, Fritisch EF, Maniatis T: Molecular cloning: a laboratory manual,
Cold Spring Harbor Laboratory. New York: Cold Spring Harbor; 1989.
19. Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, Jrad BB, Remadi S,
Chouchane L: Genetic variation in the tumor necrosis factor-alpha
promoter region and in the stress protein hsp70-2: susceptibility and
prognostic implications in breast carcinoma. Cancer 2001, 91:672–678.
20. Chouchane L, Ahmed SB, Baccouche S, Remadi S: Polymorphism in the
tumor necrosis factor-alpha promotor region and in the heat shock
protein 70 genes associated with malignant tumors. Cancer 1997,
80:1489–96.
21. Kazemi-Bajestani SM, Ghayour-Mobarhan M, Ebrahimi M, Moohebati M,
Esmaeili HA, Ferns GA: C-reactive protein associated with coronary artery
disease in Iranian patients with angiographically defined coronary artery
disease. clin Lab 2007, 53:49–56.
22. Francis MC, Frohlich JJ: Coronary artery disease in patients at low risk–
apolipoprotein AI as an independent risk factor. Atherosclerosis 2001,
155:165–170.
23. Chouchane L, Danguir J, Beji C, Bouassida K, Camoin L, Sfar H, Gabbouj S,
Strosberg AD: Genetic variation in the stress protein hsp70-2 gene is
highly associated with obesity. Int J Obes Relat Metab Disord 2001,
25:462–466.
24. Nakhjavani M, Morteza A, Asgarani F, Khalilzadeh O, Ghazizadeh Z, Bathaie
SZ, Esteghamati A: The dual behavior of heat shock protein 70 and
asymmetric dimethylarginine in relation to serum CRP levels in type 2
diabetes. Gene 2012, 498:107–111.
25. Zhu J, Quyyumi AA, Wu H, Csako G, Rott D, Zalles-Ganley A, Ogunmakinwa
J, Halcox J, Epstein SE: Increased serum levels of heat shock protein 70
are associated with low risk of coronary artery disease. Arterioscler
Thromb Vasc Biol 2003, 23:1055–1059.
doi:10.1186/1746-1596-7-88
Cite this article as: Hrira et al.: Hsp70-2 gene polymorphism:
susceptibility implication in Tunisian patients with coronary artery
disease. Diagnostic Pathology 2012 7:88.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
